• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Interventions to reduce weight gain in schizophrenia.减少精神分裂症患者体重增加的干预措施。
Schizophr Bull. 2007 May;33(3):654-6. doi: 10.1093/schbul/sbm022. Epub 2007 Apr 21.
2
The role of lifestyle interventions and weight management in schizophrenia.生活方式干预和体重管理在精神分裂症中的作用。
J Psychopharmacol. 2005 Nov;19(6 Suppl):28-35. doi: 10.1177/0269881105058682.
3
Antipsychotic induced weight gain in schizophrenia:mechanisms and management.精神分裂症中抗精神病药物所致体重增加：机制与管理
Aust N Z J Psychiatry. 2008 May;42(5):369-81. doi: 10.1080/00048670801961123.
4
Schizophrenia and obesity: impact of antipsychotic medications.精神分裂症与肥胖：抗精神病药物的影响
J Clin Psychiatry. 2004;65 Suppl 18:13-26.
5
Management of weight gain in patients with schizophrenia.精神分裂症患者体重增加的管理。
J Clin Psychiatry. 2002;63 Suppl 4:33-6.
6
Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia.抗精神病药物所致体重增加及代谢异常：对精神分裂症患者死亡率增加的影响
J Clin Psychiatry. 2004;65 Suppl 7:4-18; quiz 19-20.
7
The clinical implications of weight gain in schizophrenia.精神分裂症患者体重增加的临床意义。
J Clin Psychiatry. 2001;62 Suppl 7:32-7.
8
Schizophrenia, obesity, and antipsychotic medications: what can we do?精神分裂症、肥胖症与抗精神病药物：我们能做些什么？
Postgrad Med. 2008 Jul;120(2):18-33. doi: 10.3810/pgm.2008.07.1786.
9
Can metformin or rosiglitazone reduce metabolic side effects associated with atypical antipsychotics?二甲双胍或罗格列酮能否减轻非典型抗精神病药物相关的代谢副作用？
Issues Ment Health Nurs. 2009 Dec;30(12):803-5. doi: 10.3109/01612840903276712.
10
[Metabolic risk during antipsychotic treatment in patients with schizophrenia].[精神分裂症患者抗精神病药物治疗期间的代谢风险]
Psychiatr Pol. 2007 Jul-Aug;41(4):457-72.

引用本文的文献

1
Alterations and potential associations of repetitive transcranial magnetic stimulation on body weight in stable schizophrenic patients.重复经颅磁刺激对稳定期精神分裂症患者体重的影响及潜在关联。
Schizophrenia (Heidelb). 2025 Apr 28;11(1):72. doi: 10.1038/s41537-025-00621-1.
2
Evidence and gap map of studies assessing the effectiveness of interventions for people with disabilities in low-and middle-income countries.评估中低收入国家残疾人干预措施有效性的研究证据与差距图。
Campbell Syst Rev. 2020 Jan 9;16(1):e1070. doi: 10.1002/cl2.1070. eCollection 2020 Mar.
3
Effect of Repetitive Transcranial Magnetic Stimulation in Inducing Weight Loss in Patients with Chronic Schizophrenia: A Randomized, Double-Blind Controlled 4-Week Study.重复经颅磁刺激对慢性精神分裂症患者体重减轻的影响：一项随机、双盲对照的 4 周研究。
Curr Neuropharmacol. 2023;21(2):417-423. doi: 10.2174/1570159X20666220524123315.
4
Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries.中低收入国家针对患有精神障碍的成年人预防2型糖尿病的干预措施。
Cochrane Database Syst Rev. 2021 Feb 16;2(2):CD013281. doi: 10.1002/14651858.CD013281.pub2.
5
Antipsychotic-associated weight gain: management strategies and impact on treatment adherence.抗精神病药物所致体重增加：管理策略及其对治疗依从性的影响
Neuropsychiatr Dis Treat. 2017 Aug 22;13:2231-2241. doi: 10.2147/NDT.S113099. eCollection 2017.
6
Design of the Lifestyle Interventions for severe mentally ill Outpatients in the Netherlands (LION) trial; a cluster randomised controlled study of a multidimensional web tool intervention to improve cardiometabolic health in patients with severe mental illness.荷兰严重精神疾病门诊患者生活方式干预设计（LION）试验；一项关于多维网络工具干预以改善严重精神疾病患者心脏代谢健康的整群随机对照研究。
BMC Psychiatry. 2017 Mar 21;17(1):107. doi: 10.1186/s12888-017-1265-7.
7
The Effectiveness of Pharmacological and Non-Pharmacological Interventions for Improving Glycaemic Control in Adults with Severe Mental Illness: A Systematic Review and Meta-Analysis.药物和非药物干预对改善重度精神疾病成人患者血糖控制的有效性：一项系统评价与荟萃分析
PLoS One. 2017 Jan 5;12(1):e0168549. doi: 10.1371/journal.pone.0168549. eCollection 2017.
8
Effect of GLP-1 receptor agonist treatment on body weight in obese antipsychotic-treated patients with schizophrenia: a randomized, placebo-controlled trial.胰高血糖素样肽-1受体激动剂治疗对肥胖的精神分裂症抗精神病药物治疗患者体重的影响：一项随机、安慰剂对照试验。
Diabetes Obes Metab. 2017 Feb;19(2):162-171. doi: 10.1111/dom.12795. Epub 2016 Nov 14.
9
Physical activity preferences of individuals diagnosed with schizophrenia or bipolar disorder.被诊断患有精神分裂症或双相情感障碍的个体的身体活动偏好。
BMC Res Notes. 2016 Jul 12;9:340. doi: 10.1186/s13104-016-2151-y.
10
Does participation in a weight control program also improve clinical and functional outcomes for Chinese patients with schizophrenia treated with olanzapine?参加体重控制项目是否也能改善接受奥氮平治疗的中国精神分裂症患者的临床和功能结局？
Neuropsychiatr Dis Treat. 2014 Jul 10;10:1287-96. doi: 10.2147/NDT.S60246. eCollection 2014.

Interventions to reduce weight gain in schizophrenia.

作者信息

Faulkner Guy, Cohn Tony, Remington Gary

机构信息

Faculty of Physical Education and Health, University of Toronto, Toronto, Canada.

出版信息

Schizophr Bull. 2007 May;33(3):654-6. doi: 10.1093/schbul/sbm022. Epub 2007 Apr 21.

DOI:10.1093/schbul/sbm022
PMID:17449900
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2526141/
Abstract
摘要